Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
Fixed Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 0.380.350.340.310.27

What is the latest Fixed Capital/Sales ratio of AUROBINDO PHARMA ?

The latest Fixed Capital/Sales ratio of AUROBINDO PHARMA is 0.38 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20250.38
Mar20240.35
Mar20230.34
Mar20220.31
Mar20210.27

How is Fixed Capital/Sales of AUROBINDO PHARMA Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.38
8.57
Mar2024 0.35
2.94
Mar2023 0.34
9.68
Mar2022 0.31
14.81
Mar2021 0.27 -

Other Financial Ratios of AUROBINDO PHARMA


Compare Fixed Capital/Sales ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹82,607.3 Cr -7.2% 1.3% 23.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹442,677.0 Cr -2.4% 6.4% 7% Stock Analytics
DIVIS LABORATORIES ₹180,458.0 Cr -0.9% 5% 3.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹153,685.0 Cr 1.6% 7.6% 38.5% Stock Analytics
CIPLA ₹114,562.0 Cr 1.2% 7.7% -3.4% Stock Analytics
DR REDDYS LABORATORIES ₹110,095.0 Cr 0.1% -1.2% 8.7% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-7.2%

1.3%

23.2%

SENSEX

0.7%

-1%

-7%


You may also like the below Video Courses